Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

COVID-19 can cause temporary hair loss due to stress and inflammation.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Secondary syphilis in Cali, Colombia, shows high Treponema pallidum presence and challenges in early diagnosis, needing better public health strategies.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

The combination of Arginine Silicate Inositol Complex and a new form of Biotin improved hair and nail growth in rats.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

Pandemic stress worsens hair loss and skin issues, suggesting combined mental and skin care treatments.

Fibroblast growth factors could be a better, safer treatment for hair loss than current options.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

During COVID-19, Iraqi women saw more hair loss and skin issues like acne due to stress, masks, and hygiene habits.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.

During COVID-19, Iraqi women experienced more hair loss and skin issues like acne, likely due to stress and mask-wearing.

New understanding and treatments for hair loss are improving, but more research is needed.

Skin symptoms appear in up to 20% of Covid-19 cases.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

Five FDA-approved drugs may help block COVID-19 virus entry.

Perilla frutescens is a versatile herb with health benefits and potential in food and industrial uses.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Myristoleic acid helps hair growth by boosting cell growth and recycling processes in hair follicle cells.